https://scholars.lib.ntu.edu.tw/handle/123456789/630932
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Su, Yung-Yeh | en_US |
dc.contributor.author | Chiang, Nai-Jung | en_US |
dc.contributor.author | Yang, Yi-Hsin | en_US |
dc.contributor.author | Yen, Chia-Jui | en_US |
dc.contributor.author | Bai, Li-Yuan | en_US |
dc.contributor.author | Chiu, Chang-Fang | en_US |
dc.contributor.author | Chuang, Shih-Chang | en_US |
dc.contributor.author | SHIH HUNG YANG | en_US |
dc.contributor.author | Chou, Wen-Chi | en_US |
dc.contributor.author | Chen, Jen-Shi | en_US |
dc.contributor.author | Chiu, Tai-Jan | en_US |
dc.contributor.author | Chen, Yen-Yang | en_US |
dc.contributor.author | Chan, De-Chuan | en_US |
dc.contributor.author | Peng, Cheng-Ming | en_US |
dc.contributor.author | Chiu, Sz-Chi | en_US |
dc.contributor.author | Li, Chung-Pin | en_US |
dc.contributor.author | Shan, Yan-Shen | en_US |
dc.contributor.author | Chen, Li-Tzong | en_US |
dc.date.accessioned | 2023-05-09T01:39:30Z | - |
dc.date.available | 2023-05-09T01:39:30Z | - |
dc.date.issued | 2023-02-05 | - |
dc.identifier.issn | 2072-6694 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/630932 | - |
dc.description.abstract | The nomogram derived from the pivotal phase III NAPOLI-1 study demonstrated a significant ability to predict median overall survival (OS) in gemcitabine-refractory metastatic pancreatic ductal adenocarcinoma (PDAC) treated with liposomal irinotecan plus fluorouracil and leucovorin (nal-IRI+5-FU/LV). However, the NAPOLI-1 nomogram has not been validated in a real-world setting and therefore the applicability of the NAPOLI-1 nomogram in daily practice remains unknown. This study aims to evaluate the NAPOLI-1 nomogram in a multicenter real-world cohort. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MDPI | en_US |
dc.relation.ispartof | Cancers | en_US |
dc.subject | nal-IRI; nomogram; pancreatic cancer; real-world | en_US |
dc.title | Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.3390/cancers15041008 | - |
dc.identifier.pmid | 36831353 | - |
dc.identifier.scopus | 2-s2.0-85149117119 | - |
dc.identifier.isi | WOS:000938492500001 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85149117119 | - |
dc.relation.journalvolume | 15 | en_US |
dc.relation.journalissue | 4 | en_US |
item.fulltext | no fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.openairetype | journal article | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。